Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GEGR Purchases Major Interest in a Revolutionary Green Energy New Battery Patent Holder, Protonstar SAGL for $20 Million Salt Lake City, Utah--(Newsfile Corp. - December 20, 2021) - Gaensel Energy Group, Inc., (OTC Pink: GEGR) ("Gaensel" or the "Company"), a diversified holding company with assets in Biotech and other different industries, is pleased to announce its agreement to acquire 30% of Protonstar SAGL, a Swiss Research & Development and trade of technological devices company in the energy sector, including its Patent. PCT/IB2018/051315. Protonstar holds the patent on the "Protonstar Battery System, which is a "Hydrogen Nickel based energy storage system." The storage system is a revolutionary new kind of battery that hopes to disrupt in the energy market and provide pollution free energy for both the commercial and retail markets.
https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html
$GEGR BIG NEWS OUT - Purchases Major Interest in a Revolutionary Green Energy New Battery Patent Holder, Protonstar SAGL for $20 Million https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html
Peter Koley, the Chief Financial Officer for Gaensel Energy, states: "This new important acquisition represents for our Group an increased investment in the global much needed renewable energy technology and is also a major step for Gaensel Energy Group to start a process of identifying the best return on investment and focus the energies of our group in this space."
$GEGR
$ADMQ Barwicki Investor Relations will provide the investment community with information and updates about ADM Endeavors through the distribution of ADMQ Fact Sheets, scheduling road shows, conference calls, and one-on-one meetings with institutional investors and broker dealers throughout the United States. The investor relations program will also target retail investors and investors within our specific industry.
https://finance.yahoo.com/news/adm-endeavors-inc-retains-barwicki-173300257.html
$JZZI News Out - Based on Latest Research, JZZ Technologies, Inc. Announces New Immune Boost and Anti-Inflammatory Products Developed Through Nutrific Inc.
New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm
West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line.
The new research focuses on the body's negative reaction to viruses, such as the SARS-2 virus among others. International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products.
The Nutrific products aim to specifically address the transduction (signaling) process in inflammatory disorders to mitigate the worst effects of a virus and the body's response to them.
These two areas represent massive markets where a relevant natural treatment could provide significant revenues through a patented treatment. The global immune health supplements market is projected to grow from $20.18 billion in 2021 to $31.50 billion in 2028 at a CAGR of 6.6% from 2021 to 2028 (source: Fortune Business Insights).Alongside the immune health market, the Global Anti-Inflammatory Therapeutics market size is estimated to grow at CAGR of almost 6% with USD 27.53 billion during the forecast period 2021-2024 (source: MarketWatch). These are the two markets that Nutrific expects to enter with its new products.
Based on GenBio Inc.'s own internal research in Australia with its CSO coordinating translational research, treatment must address the following factors:
Certain viruses initiate a reaction from the immune system which thus creates an inflammatory response, including Cytokine Storm (CS)
CS is an accelerated production of an array of pro-inflammatory cytokines
CS then instigates different inflammatory pathways via their receptors on immune and tissue cells
This creates a variety of symptoms. CS can be a life-threatening clinical condition in which the excessive overproduction of both inflammatory cytokines and excessive activation of immune cells leads to medical complications
Current research focus by the GenBio team is on identifying natural extracts (and their key antioxidant molecules) than can reduce the intensity/severity of CS, particularly in the early stages. Particular attention will be paid to attempt to confine mechanisms of action to dampening specific immune pathways without impairing the host defense
Up to 50% of the people who have died from COVID-19 had metabolic and vascular disorders. Notably, there are many direct links between COVID-19 and the metabolic and endocrine systems. Thus, not only are patients with metabolic dysfunction (e.g., obesity, hypertension, non-alcoholic fatty liver disease, and diabetes) at an increased risk of developing severe COVID-19, but also infection with SARS-CoV-2 might lead to new-onset diabetes or aggravation of pre-existing metabolic disorders
Giles Tilley, CEO Of GenBio Inc., stated, "Significantly, these issues all attest to the immediate use of rare bioactive Australian natural extracts in the reduction of anti-inflammatory or anti thrombotic situations in a system wide occurrence in both healthy and overweight/obese populations."
"Metabolic dysfunction might lead to a baseline state of chronic inflammation, given that proinflammatory cytokines, such as TNFa, IL-6, and IL-1ß, are upregulated in the adipose tissue of patients with metabolic syndrome," added Tilley.
As part of its efforts to keep pace with the significant expansion that its biotechnology and biosciences operations will create, JZZ Technologies Inc. is reviewing the potential for new corporate headquarters. Management is in discussions with several governmental and trade groups to establish the best, most flexible solution for the scaling of the company for the foreseeable future.
About GenBio Inc.
Based in Aliso Viejo, California, GenBio, Inc. (www.genbioinc.com) is an early-stage biotechnology company researching novel therapeutics from a variety of extracts. Based on recent US research, the company has created an Investigational New Drug (IND) research program from novel natural compounds that are highly effective as anti-inflammatory agents. CSO, Professor Lindsay Brown, is a renowned international researcher leading GenBio's product development and research. The company also has access to other global scientific teams that are investigating specific properties for the same new, disruptive molecular platforms for pain relief, anti-inflammation, and age-related healthcare issues.
About JZZ Technologies, Inc.
JZZ Technologies, Inc. is a diversified technology company engaged in the following two distinct business sectors: (i) its digital media business, which includes online media and apps (activelifestylemedia.com), content creation, digital marketing, streaming video content, publishing, and free over-the-air television (EyeOnTV) targeted to active adults 55+, and; (ii) strategic biotechnology and bioscience-related to Human Life Extension and Human Longevity that can be immediately leveraged to support improved quality of life for the senior population.
https://www.newsfilecorp.com/release/108305/Based-on-Latest-Research-JZZ-Technologies-Inc.-Announces-New-Immune-Boost-and-AntiInflammatory-Products-Developed-Through-Nutrific-Inc.
$AVCO News Out! Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market https://finance.yahoo.com/news/avalon-globocare-chairman-converts-debt-140000861.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo
$LLLI New Tweet - Lamperd Less Lethal offers a special Green Pepper Splatter Munition option which stays concentrated on an individual target so as not to contaminate any facility air vents or ductwork.
@Lamperd_LLLI
$LLLI Lamperd Less Lethal offers a special Green Pepper Splatter Munition option which stays concentrated on an individual target so as not to contaminate any facility air vents or ductwork. @Lamperd_LLLI pic.twitter.com/8qDA5X2PKq
— LamperdLessLethal (@LLLI_LessLethal) December 22, 2021
$GEGR At the same time, green hydrogen is gaining favor as a way to clean up long-distance transportation, chemical manufacturing, aviation, and other sectors that are difficult to electrify. Estimates for green hydrogen growth vary widely, and there's little consensus as to what demand might look like in coming decades, Canary Media recently reported. However, the Hydrogen Council said it expects green hydrogen production to reach nearly 550 million metric tons by 2050-a significant jump from the roughly 0.36 million metric tons produced in 2019.
$GEGR Peter Koley, the Chief Financial Officer for Gaensel Energy, states: "This new important acquisition represents for our Group an increased investment in the global much needed renewable energy technology and is also a major step for Gaensel Energy Group to start a process of identifying the best return on investment and focus the energies of our group in this space."
$GPGC News : Global PoleTrusion Group Corp Provides Letter from the President of the Company
https://finance.yahoo.com/news/global-poletrusion-group-corp-provides-140200582.html
$JZZI News : Working with respected bioscience companies JZZ Technologies, Inc. intends to advance five novel therapeutics utilizing natural compounds for age-related healthcare issues.
West Palm Beach, Florida--(Newsfile Corp. - December 1, 2021) - As announced via press release on November 16, 2021, JZZ Technologies, Inc. (OTC Pink: JZZI) signed an LOI with NutraEdge Bioscience Corp. dated November 10, 2021. This press release supplements the release of November 16, 2021. JZZ Technologies, Inc. intends to continue its due diligence on the target acquisition, a US Biotechnology Company that has a range of natural healthcare formulations assigned to it, which are largely unknown in the USA, and that demonstrate bioactivity and antimicrobial activity.
Under the terms of the Letter of Intent, dated November 10, 2021, JZZ Technologies, Inc. will acquire 100% ownership of NutraEdge Biosciences Corp., 5% of GenBio Inc. and 25% of Nutrific.
https://finance.yahoo.com/news/jzz-technologies-inc-acquisition-company-151500585.html
$ADMQ News : Barwicki Investor Relations will provide investor relations and shareholder communications services and assist the company in expanding market awareness and engagement with the institutional and retail investment communities. https://finance.yahoo.com/news/adm-endeavors-inc-retains-barwicki-173300257.html
$GEGR The system is able to store energy in the nanometrically deposited Nickel matrix on an alumina support.
The differences between the new Protonstar Battery System as compared to currently available technology is:
Not chemically based
Not Lithium based
Has theoretically unlimited charge/discharge cycles
Battery lifespan subject to electronics controls circuits
$ADMQ News : ADM Endeavors, Inc. (OTCQB: ADMQ) Announces Three New Government Contracts https://finance.yahoo.com/news/adm-endeavors-inc-otcqb-admq-173300013.html
$GEGR Currently in the development stage, the battery itself, as describe by the company, is an, "Energy storage system composed of an electric generator, an electrochemical cell inside which an insulating substrate is inserted and onto which a nickel matrix is deposited, the roughness of which has a peak of about 5nm
$GPGC Getting loaded here, don't miss the process news update coming soon...
$GEGR announce its agreement to acquire 30% of Protonstar SAGL, a Swiss Research & Development and trade of technological devices company in the energy sector, including its Patent. PCT/IB2018/051315. Protonstar holds the patent on the "Protonstar Battery System, which is a "Hydrogen Nickel based energy storage system." The storage system is a revolutionary new kind of battery that hopes to disrupt in the energy market and provide pollution free energy for both the commercial and retail markets.
https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html
$GEGR #Breakingnews @GEGRGroup Energy Group, Inc. (GEGR) Purchases Major Interest in a Revolutionary Green Energy New Battery Patent Holder, Protonstar SAGL for $20 Million
https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html $CEOS $HMNU $TSLA $FB $TWTR
$GEGR #Breakingnews @GEGRGroup Energy Group, Inc. (GEGR) Purchases Major Interest in a Revolutionary Green Energy New Battery Patent Holder, Protonstar SAGL for $20 Million
https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html $CEOS $HMNU $TSLA $FB $TWTR
$GEGR #Breakingnews @GEGRGroup Energy Group, Inc. (GEGR) Purchases Major Interest in a Revolutionary Green Energy New Battery Patent Holder, Protonstar SAGL for $20 Million
https://finance.yahoo.com/news/gaensel-energy-group-inc-gegr-134500660.html $CEOS $HMNU $TSLA $FB $TWTR
$JZZI @Barcjart opinion https://www.barchart.com/stocks/quotes/JZZI/opinion
More news update coming here.. $GEGR
$ADMQ News ; Dec 16, 2021 - ADM Endeavors, Inc. Retains Barwicki Investor Relations to Provide a Global Investor Relations Program
https://finance.yahoo.com/news/adm-endeavors-inc-retains-barwicki-173300257.html
$ADMQ News ; Dec 16, 2021 - ADM Endeavors, Inc. Retains Barwicki Investor Relations to Provide a Global Investor Relations Program
https://finance.yahoo.com/news/adm-endeavors-inc-retains-barwicki-173300257.html
Looks good dip buy opportunity, + 250% up year to date! Keep rollin3x $GPGC
$SITS Up + +825.93% Year-to-Date
$JZZI Traders cheat sheet https://www.barchart.com/stocks/quotes/JZZI/cheat-sheet
$JZZI Chart looks ready for a breakout here https://schrts.co/bYCjYQYZ
$ADMQ Strong buy ratings @barchart https://stockcharts.com/h-sc/ui?s=ADMQ
$CEOS The company has successfully navigated unprecedented difficulty with regard to the effects of COVID19 on international supply chains by securing 900 kilograms of premium quality mushrooms, complete with certificates of analysis from approved producers. Upon final approval of PsyKey's product formulations, the six different functional mushroom strains will be used in the development of our retail product offerings. The procurement of these ingredients has been overseen by a highly qualified mycologist, aligning with our commitment at the forefront of the company's retail vision to offer consumers the highest quality ingredients and products. https://finance.yahoo.com/news/psykey-inc-corporate-134500303.html
$GEGR The Company is finalizing legal counsel's review of its Spin-Off plan for certain entities within the group to maximize shareholder value. The Swiss Stem Cell Biotech and RE-YOU SUISSE are engaged for this initial transaction. We will be providing updates shortly. https://twitter.com/GEGRGroup/status/1470427215573700613
$IVDN Innovative Designs Common Stock Listed on OTCQB
https://finance.yahoo.com/news/innovative-designs-common-stock-listed-184800997.html
$IVDN Up 40% strong buy ratings @barchart
On my watch list here $IVDN
$ADMQ before a stock price moves, volume comes into play!!
$ADMQ Chart setting up nicely here.
$GPGC + 250% Year to date!
$GPGC + 250% Year to date!